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Abstract
Objective—Although low weight is a key factor contributing to the high mortality in anorexia
nervosa (AN), it is unclear how AN patients sustain low weight compared with bulimia nervosa
(BN) patients with similar psychopathology. Studies of genes involved in appetite and weight
regulation in eating disorders have yielded variable findings in part due to small sample size and
clinical heterogeneity. This study: (1) assessed the role of leptin, melanocortin, and neurotrophin
genetic variants in conferring risk for AN and BN and (2) explored the involvement of these genes
in body mass index (BMI) variations within AN and BN.
Method—Our sample consisted of 745 individuals with AN without a history of BN, 245 with
BN without a history of AN, and 321 controls. We genotyped 20 markers with known or putative
function among genes selected from leptin, melanocortin, and neurotrophin systems.
Results—There were no significant differences in allele frequencies among individuals with AN,
BN, and controls. AGRP rs13338499 polymorphism was associated with lowest illness-related
BMI in those with AN (p=0.0013), and NTRK2 rs1042571 was associated with highest BMI in
those with BN (p=0.0018).
Discussion—To our knowledge, this is the first study to address the issue of clinical
heterogeneity in eating disorder genetics and to explore the role of known or putatively functional
markers in genes regulating appetite and weight in individuals with AN and BN. If replicated, our
results may serve as an important first step toward gaining a better understanding of weight
regulation in eating disorders.
Keywords
anorexia nervosa; bulimia nervosa; candidate gene association; body weight; melanocortins;
neurotrophins
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Indifference to extreme weight loss and low motivation to restore normal body mass are the
sine qua nons of anorexia nervosa (AN) and the primary target of initial treatment
(American Psychiatric Association, 2006). As the illness is often protracted, low BMI and
the avoidance of eating to restore healthy weight are primary factors influencing high
morbidity and mortality that distinguish this illness. Low weight (and the permissive factors
involved) are of interest for additional reasons as these are key aspects of AN; moreover,
low body weight is the primary distinguishing diagnostic feature separating AN from
bulimia nervosa (BN; American Psychiatric Association, 2013) and is associated with other
clinical phenotypes, anxiety in particular (Dellava et al, 2010; Thornton et al, 2011).
To date, the genetic risk architecture underlying eating disorders (EDs) remains largely
unexplored; however, like most other psychiatric illnesses, the heritability of EDs appears to
follow a non-Mendelian pattern, suggesting that large numbers of genes spanning multiple
regions of the genome are involved in susceptibility. While a number of ED candidate gene
studies have investigated neurotransmitter systems involved in motivated behaviors (Hinney
et al, 1997; Gorwood et al, 2002; Hu et al, 2003; Ricca et al, 2004; Nisoli et al, 2007; Sorli
et al, 2008; Frieling et al, 2010), the results have been unpersuasive. Other studies that
focused on regulators of appetite and weight have yet to implicate specific and replicable
polymorphisms or gene-phenotype associations (Hinney et al, 1998; Vink et al, 2001;
Janeckova, 2001; Quinton et al., 2004; Cellini et al, 2006; Monteleone et al, 2006;
Dardennes et al, 2007), whereas a number of genes with effects on appetite and weight
regulation have yet to be examined in EDs (Table 1). Similarly, although neurotrophin
system genes have also been implicated in EDs in case-control studies (Ribases et al, 2003;
2004; 2005a; 2005b; Dmitrzak-Weglarz et al, 2007; Kaplan et al, 2008; Mercader et al,
2008), a recent meta-analysis has called into question the significance the reliability of some
of these findings (Brandys et al, 2013), while the other findings await replication.
Furthermore, genome-wide association studies (GWAS) of obesity have identified new
genetic variants with potential implication for ED phenotypes; for instance, common
variants near the melanocortin 4 receptor (MC4R) gene have been repeatedly associated with
BMI in obesity (e.g., Loos et al, 2008; Luan et al, 2009; Thorleifsson et al, 2009; Speliotes
et al, 2010; Elks et al, 2010; Scherag et al, 2010; Beckers et al, 2011; Kvaloy et al, 2013);
although thus far this marker has not yielded positive findings in AN (Brandys et al., 2010),
it requires further investigation. MC4R variants have also been associated with antipsychotic
medication-induced weight gain (Malhotra et al, 2012; Chowdhury et al, 2013); however,
the relevance of these variants with promising findings to ED phenotype variation currently
remains unknown.
A complication in genetic studies of EDs is instability of the phenotype as the crossover
between ED diagnoses, in particular from AN to BN, is upwards of 34-36% (Tozzi et al,
2005; Eddy et al, 2008), and most crossover occurs within five years from time of AN onset.
By contrast, the BN to AN crossover is less common (Fichter and Quadflieg, 1997; Tozzi et
al, 2005; Eddy et al, 2008). For this reason, clearly defining AN and BN phenotypes
considering longitudinal course of illness is important to the design of genetic studies, as
weight histories of AN and BN often diverge, and BN patients with prior AN histories
Yilmaz et al. Page 3






















usually report significantly lower current, maximum, and minimum BMIs than BN patients
without histories of AN (Kaye et al, 2004); premorbid obesity is more prevalent in those
with BN compared with those with AN (33.2% vs. 4.6%, respectively; Villarejo et al, 2012);
and a higher maximum lifetime BMI may be a predictor of AN to BN crossover
(Monteleone et al, 2011).
The present study had two aims: first, to investigate single nucleotide polymorphisms
(SNPs) with known, or putative, functions in the leptin, melanocortin, and neurotrophin
system genes in individuals with AN, BN, and healthy controls; second, to explore the role
of the selected candidate genes on illness-related minimum BMI, maximum lifetime BMI,
and BMI at the time of ascertainment in each clinical group (AN and BN) separately.
METHODS AND MATERIALS
Sample Selection
The main sample used for the selection of suitable cases was derived from the Price
Foundation Consortium. All participants included in this collaborative initiative were
carefully phenotyped, and these procedures and sample characteristics have been previously
described in detail (Kaye et al, 2000; Kaye et al, 2004; Jacobs et al, 2009). The present study
consisted of a subgroup of female participants who either had AN with no history of BN
(AN) or BN with no history of AN (BN; Supplementary Table 1). Minimum illness duration
was three years for individuals in each diagnostic group to ensure stability of ED diagnosis.
The AN group included individuals with the restricting (AN-R), binge/purge and purging
(combined as AN-BP) subtypes. It was ensured that the individuals classified as AN-BP had
no history of BN, i.e., regular binge eating and purging when not underweight.
Additional DNA samples from females with BN with no history of AN were selected from
the Toronto Bulimia Nervosa Genetics Study (Supplementary Table 1), stored at the Centre
for Addiction and Mental Health (CAMH) Neurogenetics Laboratory in Toronto, Canada.
Recruitment criteria for this study closely followed those of the Price Foundation BN cases,
and the details on recruitment have been published elsewhere (Yilmaz et al, 2011; Yilmaz et
al, 2012). Finally, DNA samples from female controls with no psychiatric history (as
assessed by a self-report checklist) were obtained from the Toronto Centre for Applied
Genomics. Since the controls were not screened for EDs, we only included individuals with
a BMI between 19 kg/m2 and 28 kg/m2 to avoid extreme weight phenotypes (Supplementary
Table 1).
All aspects of this research study were reviewed and approved by the CAMH Research
Ethics Board and conducted in accordance with the Helsinki Declaration as revised in 1989.
Informed consent for providing genetic materials and inclusion of these materials in future
collaborative studies was obtained from all individuals whose DNA samples were included
in our analysis.
Laboratory Methods
Our genetic analysis focused on 11 candidate genes in the leptin (LEPR, LEP, GHRL,
HRH1), melanocortin (MC3R, MC4R, AGRP, POMC), and neurotrophin (BDNF, NTRK2,
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NTRK3) systems. We pursued a targeted approach that focused on SNPs with known or
putative function, as assessed by in silico analysis. This approach has a number of
advantages over the tag SNP approach: first, the study of functional variants helps us make
more biologically meaningful discoveries as to the effects of any genetic differences
associated with the phenotype being studied; second, focusing on a small number of
carefully selected loci reduces multiple testing and requires less stringent statistical
correction. Two in silico tools were used: the National Institute of Environmental Health
Sciences (http://snpinfo.niehs.nih.gov) and BrainArray (http://
brainarray.mbni.med.umich.edu). On average, two markers per gene were selected. Priority
was given to SNPs that have been studied in EDs, and a small number of SNPs without
known function were also included based on the promising findings they have yielded in
EDs despite small sample size (NTRK2 rs1078947), obesity (MC4R rs17782313),
antipsychotic medication-induced weight gain (MC4R rs489693 and rs8087522; Table 1).
Genomic DNA was extracted from whole blood for Price Foundation samples and from
lymphocytes for Toronto BN cases and healthy controls using the high salt method (Lahiri
and Nurnberger, 1991). All genotyping was performed using standard protocols for Applied
Biosystems OpenArray® and ViiA™ 7 platforms at CAMH, blind to diagnosis.
Statistical Analysis
Chi-square, t-test, and analysis of variance on anthropometric, demographic, and disease
characteristics across AN, BN, and controls were performed using SPSS Statistics v17
(SPSS Inc., Chicago, USA, 2008). Quality control (QC) steps prior to data analysis
consisted of checking for deviations from Hardy-Weinberg Equilibrium (HWE; cutoff
p<0.01), removal of SNPs with low minor allele frequency (MAF; <0.03) and low
genotyping rate (<90%), and exclusion of individuals with low genotyping rate (<90%). For
case-control analysis, genotype and ED diagnosis were treated as categorical variables. The
chi-square test was performed for the case-control comparisons using PLINK (Purcell et al,
2007). Power calculations were carried out using Quanto v.1.2.4 (http://hydra.usc.edu/gxe),
and we have over 90% power to detect an odds ratio as low as 1.5 (alpha=0.05, two-tailed,
MAF=0.10, log additive model).
For the quantitative phenotypic analysis, we investigated the role of the genetic
polymorphisms on three BMI measures: BMI at recruitment (curBMI), maximum lifetime
BMI (maxBMI), and lowest illness-related BMI (minBMI). Quantitative data were analyzed
separately in AN and BN using linear regression in PLINK. Age, age of onset, AN subtype
(for AN only) and source (Price Foundation versus Toronto; for BN only) were entered as
covariates, where appropriate, and we have over 80% power to detect a mean change of 0.6
kg/m2 in BMI for the AN group (alpha=0.05, two-tailed, MAF=0.10, log additive model).
We corrected for multiple testing using Single Nucleotide Polymorphism Spectral
Decomposition (SNPSpD; Nyholt, 2004; Li and Ji, 2005). This method calculates the
effective number of independent loci for the SNPs on the same gene using linkage
disequilibrium (LD) information (Nyholt, 2004; Li and Ji, 2005). Once the effective number
of independent loci was determined per gene, the adjusted alpha was calculated by dividing
the uncorrected p-value of 0.05 by the effective number of independent SNPs. In our study,
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the effective number of independent SNPs was determined to be 18.75, setting the adjusted
p<0.0027. All statistical analyses were two-tailed.
RESULTS
After applying the selection criteria, 787 AN cases, 267 BN cases, and 322 healthy controls
were included. Following QC, 42 AN cases, 22 BN cases, and one control were removed
due to low genotyping rate, bringing the final sample to 745 AN, 245 BN, and 321 controls.
Of the AN cases, 369 had AN-R (49.5%), whereas 376 had AN-BP (50.5%). All AN and
128 BN cases (52.2%) came from the Price Foundation Consortium, and 117 BN cases
(47.8%) came from the Toronto Bulimia Nervosa Genetics Study. Individuals removed due
to low genotyping rate did not differ from those who passed QC in terms of demographic,
anthropometric, and disease characteristics (results not shown).
In terms of sample characteristics (Table 2), controls were significantly older than AN and
BN cases (p<0.0001), whereas AN cases had a significantly lower mean curBMI compared
with the other two groups (p<0.0001). There were also significant differences between AN
and BN groups in minBMI (p<0.0001) and maxBMI (p<0.0001).
We also observed a number of differences between AN-R and AN-BP subtypes. Cases in the
AN-R group were younger (MAN-R=25.0±8.5, MAN-BP=27.2±8.4, p<0.0001), weighed less at
recruitment (MAN-R=17.85±2.79, MAN-BP=18.25±2.62, p=0.042), and reported both lower
minBMI and lower maxBMI (MAN-R=13.66±1.89, MAN-BP=13.98±1.99, p=0.025;
MAN-R=20.86±2.42, MAN-BP=21.29±2.40, p=0.013; respectively). Age of onset for AN did
not differ between subtypes (MAN-R=16.2±3.2, MAN-BP=16.2±2.9, p=0.758). When BN cases
were stratified by source, Price Foundation cases were older at recruitment
(MPrice=29.0±9.6, MToronto=25.2±6.7, p<0.0001) and had an earlier age of onset compared
with Toronto cases (MPrice=17.0±3.7, MToronto=18.0±4.2, p=0.015).
The minimum SNP genotype completion rate was 93%, with the majority of the SNPs
reaching over 98%. None of the SNPs deviated from HWE in any of the three groups, and
most of the SNPs were not correlated except for the SNPs in LEPR and MC4R, which were
in moderate linkage disequilibrium (LD; r2=0.62 and 0.77, respectively).
Results of the case-control comparisons are summarized in Supplementary Table 2. We did
not find any evidence for differences in allele frequencies between AN and BN cases, AN
and controls, or BN and controls. For the within-AN analysis of BMI, we entered age, age of
onset of AN, and AN subtype as covariates. Although age of onset was comparable between
subtypes, we chose to control for it since AN onset and weight suppression at an earlier age
may act as a confounder in the analysis. Table 3 summarizes our findings involving curBMI,
minBMI, and maxBMI in AN. None of the markers studied were linked to curBMI or
maxBMI in AN. However, AGRP rs13338499 was significantly associated with minBMI
(p=0.0013; Table 3). Table 4 presents the results of our analysis in BN, where age, age of
onset of BN, and source were entered as covariates. We did not find a significant association
between the studied markers and curBMI or minBMI. However, we observed an association
between neurotrophic tyrosine kinase receptor type 2 (NTRK2) rs1042571 and maxBMI in
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BN (Table 4), with each copy of the T allele being correlated with a mean maxBMI increase
over 1 kg/m2 (p=0.0018).
DISCUSSION
The case-control comparisons in the present study were designed to genotype a select
number of SNPs with known or putative function in the leptin, melanocortin, and
neurotrophin system genes in individuals with AN, BN, and healthy controls. Despite the
methodological strengths of this study in maximizing phenotypic differences between AN
and BN, we did not observe differences between the two ED groups and frequencies of
genetic variants included in the analysis. Furthermore, there were no differences in allele
frequencies between AN, BN, and control groups. One possible reason for this is that the
control and BN sample sizes were too small and that these sample size limitations resulted in
an underpowered analysis. In addition, differences among AN, BN, and control groups may
not be a function of vulnerability to sustained weight suppression, and future research
should focus on different gene systems and ED-related phenotypes based on different a
priori phenotypic hypotheses. Finally, it is possible that leptin-melanocortin-neurotrophin
system genes may not confer risk for AN or BN.
In the AN group, AGRP rs13338499 was significantly associated with minBMI. To our
knowledge, although the AGRP gene has been previously associated with body weight
(Bonilla et al, 2006; Li et al, 2013) and AN (Vink et al, 2001; Dardennes et al, 2007), this is
the first time this particular polymorphism has been studied in reference to BMI and EDs,
and it is not in LD with any other AGRP locus previously investigated in EDs. This finding
is intriguing on mechanistic and translational grounds, given that the Agrp knockout mouse
is one of the earliest animal models of obesity and AGRP administration ameliorates self-
starvation and hyperactivity in rats (Kas et al, 2003; Hillebrand et al, 2006). In the case of
acute AN, plasma AGRP levels are reported to be elevated (Moriya et al, 2006; Merle et al,
2011) and inversely correlated with BMI (Moriya et al, 2006). According to in silico
analysis, rs13338499 is a putative transcription factor-binding site, and, since it is located
upstream of the AGRP gene it may play a regulatory role. Considering the key orexigenic
role AGRP plays through the hypothalamus, this finding further highlights the potential
importance of the melanocortin system in weight regulation.
In the BN group, NTRK2 rs1078947 T allele was associated with higher maxBMI, a finding
that is not in agreement with a previous report that found the C allele to be linked to a higher
maxBMI in AN (Ribases et al, 2005b). A few possible explanations exist for this
discrepancy. First, since rs1078947 did not yield any significant association with any of the
three BMI measures in our 745 AN cases, the association reported in the first study might
have been a false positive related to small sample size (N=83). Second, it is possible that the
AN group in the previous study may have included individuals with a history of BN, which
may have led to the difference in the reported findings due to phenotypic heterogeneity.
Furthermore, since the previous study was conducted using Spanish ancestry cases, the
results could also be ancestry-specific. Replication studies are needed to understand the
relationship between this marker and BMI in EDs. Via its expression in the hypothalamus,
NTRK2 is involved in appetite and weight regulation; furthermore, peripheral and central
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administrations of NTRK2 agonists lead to appetite and weight suppression in animals and
reduced obesity in Bdnf knockout mice (Xu et al, 2003). This marker is not predicted to have
function in silico and was included in our study due to a previous preliminary association
reported in AN (Ribases et al, 2005b), and our results combined with the previous findings
further highlight the need for functional studies involving rs1078947.
Since a GWAS has been performed by the Price Foundation on the larger AN sample
(N=1033; Wang et al, 2011), we compared our results with the GWAS p-values for the
SNPs included in our study. Out of the 20 SNPs analyzed in this study, only six overlapped
with the GWAS, none of which was in the top 100 hits in the GWAS case-control analysis.
It is also important to note that the GWAS included AN-R cases with and without BN
history and did not look at quantitative traits such as BMI.
Despite the significant methodological strengths of this study, a number of limitations also
merit consideration. For instance, controls were significantly older than AN and BN cases.
However, it can be argued that the older age of the controls does not pose a risk to our
findings since DNA sequence is independent of age. Another possible shortcoming
involving controls is the lack of ED-specific screening; however, considering the low
prevalence of EDs and that the AN and BN groups are enriched for any genetic risk factor
for EDs, this is a conservative bias. We also did not have any lifetime BMI measures for
controls, and although we only included controls individuals within a certain BMI range, we
cannot rule out history of obesity or underweight in this group. In the case of the ED groups,
although AN sample size was one of the largest in ED candidate gene studies, BN and
control samples were smaller, which may have reduced statistical power. Although all
individuals included in the study were of European ancestry, we did not genotype ancestry
informative markers to control for population substructures. Finally, although we believe
that one of the strengths of this study is the utilization of functional variants, genotyping a
small number of SNPs and not using tag SNPs could be another criticism; it is possible that
the risk loci for EDs located in these candidate genes are outside of the markers selected and
that a tag SNP approach could provide better coverage of the genes.
If replicated, the present findings may have translational implications. For example, AGRP
is the inverse agonist of melanocortins, and data suggest that melanocortin signaling may
play a role in the regulation of circulating cholesterol: in rodents, inhibition of melanocortin
system in the central nervous system leads to an increase in high-density lipoprotein
cholesterol in a manner independent of food intake or body weight (Perez-Tilve et al, 2010).
Interestingly, the top hit in the recent Price Foundation AN high-throughput sequencing
study was in the EPHX2 gene, known to influence cholesterol function (Scott-Van Zeeland
et al, 2013). Considering that patients with AN often present with elevated cholesterol levels
(Ohwada et al, 2006; Matzkin et al, 2006; Rigaud et al, 2009; Jauregui-Garrido et al, 2012),
this clinical abnormality could be at least partially a sign of a disruption in the melanocortin
system. Furthermore, future research on the possible use of AGRP and exogenous MC4R
competitive antagonists in the treatment of AN is needed. Our results also suggest a possible
role for NTRK2 receptor agonists for individuals with BN who are overweight or obese.
BDNF is the natural NTRK2 agonist, and we are not aware of any clinical studies
investigating BDNF administration in BN or obesity. Interestingly, N-acetylserotonin,
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endogenous chemical intermediate of melatonin and serotonin, has been shown to mediate
the antidepressive effects of selective serotonin reuptake inhibitors (SSRIs) through NTRK2
agonism (Jang et al, 2010). Considering that fluoxetine is approved for the treatment of BN
and leads to a reduction in binge eating and purging (American Psychiatric Association,
2006), our findings are in line with the clinical evidence for SSRI use in the treatment of
BN, and if replicated, these results may provide an alternate, non-serotonergic mechanism of
action of SSRIs in BN through neurotrophin agonism.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 2
Characteristics of AN, BN, and control participants
AN (n=745) BN (n=267) Control (n=321) F p
Age (years)
a,b 26.1 ± 8.5 27.2 ± 8.3 49.4 ± 8.8 867.909 < 0.0001
CurBMI (kg/m2)
c 18.05 ± 2.71 23.28 ± 3.01 23.60 ± 2.16 671.019 < 0.0001
MinBMI (kg/m2)








Age data missing for one AN and one BN case
b
Control > AN = BN
c
BMI data missing for four BN cases
d
Because minBMI and maxBMI information was not available for controls, independent t-test was run to compare AN and BN groups, and the
statistic reported here is the t-value.
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